ozempic vs tirzepatide Why You Might Tolerate One Weight Loss Drug Better Than Another Tirzepatide vs. Semaglutide for Weight

Semaglutide is a long-acting GLP-1 receptor agonist with structural homology to native human GLP-1

82 MadsenKKnudsenLBAgersoeHNielsenPFThgersenHWilkenMet al

If you are participating in a clinical trial and experience a suspected side effect, you should report it via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk or through the Yellow Card app

Figure 2 3.2 Cardiometabolic parameters Two years after semaglutide cessation, all observed metabolic parameters reverted toward baseline ( Table 1 )

Many patients appreciate the ability to combine their weight loss journey with other services, such as body contouring after significant weight loss, to complete their transformation

Factors that may influence perioperative management include: Medication characteristics : Daily GLP-1 medications (liraglutide, oral semaglutide) have shorter durations of action than weekly formulations (injectable semaglutide, dulaglutide, exenatide extended-release) [3] Risk factors : Higher doses, recent dose increases, active gastrointestinal symptoms, or known gastroparesis may increase risk [1] [3] Procedure type : More complex surgeries or those requiring general anaesthesia may warrant different approaches than minor procedures Individual patient factors : BMI, presence of diabetes, and other medical conditions Some anaesthetists may recommend temporarily pausing GLP-1 therapy before certain procedures, particularly for patients with additional risk factors